{
    "ticker": "JAGX",
    "name": "Jaguar Health, Inc.",
    "description": "Jaguar Health, Inc. is a commercial-stage pharmaceutical company focused on developing and commercializing innovative products for the treatment of gastrointestinal diseases and conditions. Founded in 2013 and headquartered in San Francisco, California, Jaguar aims to leverage its proprietary technology to address unmet medical needs and improve the quality of life for patients globally. The company's lead product, Mytesi (crofelemer), is the first and only FDA-approved prescription medicine derived from the Croton lechleri tree, used to treat non-infectious diarrhea in patients with HIV/AIDS on antiretroviral therapy. In addition to Mytesi, Jaguar Health is developing a pipeline of additional therapies targeting various gastrointestinal disorders, with a strong emphasis on the potential of plant-based medicines. The company's mission is to provide safe and effective treatments while prioritizing sustainability and ethical sourcing of its natural product ingredients. With an experienced leadership team and a commitment to research and development, Jaguar Health is poised for growth as it expands its product offerings and seeks to make significant contributions to the field of gastrointestinal health.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "San Francisco, California, USA",
    "founded": "2013",
    "website": "https://www.jaguarhealth.com",
    "ceo": "Lisa Conte",
    "social_media": {
        "twitter": "https://twitter.com/JaguarHealth",
        "linkedin": "https://www.linkedin.com/company/jaguar-health-inc/"
    },
    "investor_relations": "https://investors.jaguarhealth.com",
    "key_executives": [
        {
            "name": "Lisa Conte",
            "position": "CEO"
        },
        {
            "name": "Michele Greco",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Prescription Medicines",
            "products": [
                "Mytesi"
            ]
        }
    ],
    "seo": {
        "meta_title": "Jaguar Health, Inc. | Innovative Treatments for Gastrointestinal Disorders",
        "meta_description": "Learn about Jaguar Health, Inc., a pharmaceutical company focused on developing plant-based treatments for gastrointestinal diseases. Explore their mission and product offerings.",
        "keywords": [
            "Jaguar Health",
            "Pharmaceuticals",
            "Gastrointestinal Disorders",
            "Mytesi",
            "Plant-Based Medicines",
            "FDA-Approved Treatments"
        ]
    },
    "faq": [
        {
            "question": "What is Jaguar Health known for?",
            "answer": "Jaguar Health is known for developing innovative treatments for gastrointestinal diseases, particularly its FDA-approved drug Mytesi."
        },
        {
            "question": "Who is the CEO of Jaguar Health?",
            "answer": "Lisa Conte is the CEO of Jaguar Health, Inc."
        },
        {
            "question": "Where is Jaguar Health headquartered?",
            "answer": "Jaguar Health is headquartered in San Francisco, California, USA."
        },
        {
            "question": "What is Mytesi?",
            "answer": "Mytesi (crofelemer) is the first FDA-approved prescription medicine for the treatment of non-infectious diarrhea in patients with HIV/AIDS."
        },
        {
            "question": "When was Jaguar Health founded?",
            "answer": "Jaguar Health was founded in 2013."
        }
    ],
    "competitors": [
        "SAGE",
        "HGEN",
        "XLRN"
    ],
    "related_stocks": [
        "AMGN",
        "MRNA",
        "GILD",
        "BIIB"
    ]
}